The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
October 25th 2024
New research indicates semaglutide reduced albuminuria and body weight in CKD patients without diabetes, highlighting its potential renal benefits.
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
STAMPEDE Trial: Bariatric Surgery Beats Medical Management for Obese Patients with Diabetes
April 1st 2014Trial data presented at ACC.14 showed bariatric surgery was associated with much better long-term glycemic control in obese patients with diabetes compared with standard intensive medical therapy alone.
GIPS-III Trial: No Benefit from Post-Myocardial Infarction Metformin in Non-Diabetic Patients
April 1st 2014Trial results presented at ACC.14 demonstrated that treatment with metformin immediately after PCI in non-diabetic patients presenting with acute STEMI does not lead to improvements in left ventricular ejection fraction or other measure of cardiac function.
STABILITY Trial Results: Novel Plaque Inhibitor Darapladib Fails to Show Cardiovascular Benefit
April 1st 2014Darapladib, a novel agent targeting an enzyme known to be associated with increased instability of atherosclerotic plaque, failed to show real-world benefit in a large global trial examining mortality and coronary outcomes.
Sedentary Work Is More Damaging than Simple Inactivity
March 31st 2014As more patients work in sedentary occupations, the health of the general population has declined. Some studies have revealed that sedentary workers rarely compensate for their inactivity by increasing their exercise levels and/or reducing their sedentary behavior during leisure time.
CHOICE: Balloon-Expandable Sapien Valve Shows Early Edge over CoreValve Self-Expandable Device
March 31st 2014Results from the CHOICE trial presented at ACC.14 showed the Sapien balloon-expandable valve performed slightly better than the CoreValve self-expanding device according to a composite measure of "device success."
Aleglitazar Does Not Improve Post-ACS Outcomes in Patients with Type 2 Diabetes
March 31st 2014The AleCardio trial was halted early due to safety concerns and lack of efficacy. Investigators reported patients with diabetes and acute coronary syndrome experienced elevated risk of heart failure, gastrointestinal hemorrhage, and renal dysfunction with no mitigating cardiovascular benefit.
Disappointing Results from SYMPLICITY-HTN 3 Trial of Renal Denervation in Resistant Hypertension
March 30th 2014Study data announced at ACC.14 demonstrate renal denervation does not significantly reduce blood pressure in resistant hypertension, contradicting previous studies showing the benefits of the procedure.
Exploring the Relationship between Atrial Fibrillation, Hypertension, and Stroke
Subanalysis of a study comparing warfarin and apixaban in patients with atrial fibrillation found that uncontrolled hypertension increased the risk of stroke or systemic embolism in these patients.
New PCI Guidance Aims to Increase Safety, Maintain Quality
A new guidance document on percutaneous coronary intervention (PCI) cites the need for new safety and quality protocols to address the increasing number of PCIs performed at centers with no on-site cardiac surgery backup available.